Autoimmune thrombocytopenia: A complication of fludarabine therapy in lymphoproliferative disorders
- 1 June 2000
- journal article
- case report
- Published by Wiley in Clinical and Laboratory Haematology
- Vol. 22 (3) , 175-178
- https://doi.org/10.1046/j.1365-2257.2000.00305.x
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Infections in Patients with Chronic Lymphocytic Leukemia Treated with FludarabineAnnals of Internal Medicine, 1998
- Autoimmune thrombocytopenia after six cycles of fludarabine phosphate in a patient with chronic lymphotic leukemiaHematology and Cell Therapy, 1997
- Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemiaThe Lancet, 1996
- Fludarabine‐related autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemiaBritish Journal of Haematology, 1995
- Recurrence of Autoimmune Thrombocytopenia after Treatment with Fludarabine in a Patient with Chronic Lymphocytic LeukemiaLeukemia & Lymphoma, 1994
- Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agentBlood, 1993
- Tumor lysis syndrome complicating treatment of chronic lymphocytic leukemia with fludarabine phosphateThe American Journal of Medicine, 1990